MET and neoplasm: In osteosarcoma cell lines (MG-63 and U-2OS), EGCG induced miRNA-1 upregulation and inhibited c-MET expression, while its combination with c-MET inhibitor enhanced inhibitory effects on tumor cell growth, heading to cell proliferation reduction, cell cycle arrest, and apoptosis induction [212].